Prestige Consumer Healthcare
Personal care products
Acquired Australian company Care Pharmaceuticals in 2013 and CB Fleet in 2017.

Overall

Owned USA
Rating D+
About the Ratings
Prestige Consumer Healthcare Inc
USA

Company Assessment

(Last updated Apr 2025)
Prestige Consumer Healthcare Inc
Criticism
High ESG Risk
Sustainalytics, a top ESG research firm, evaluates environmental, social, and governance risks for over 16,000 companies. Its ESG Risk Rating reflects how much risk a company faces in its industry and how well it manages those risks. The final score includes both unmanaged and unmanageable risks, and companies are rated on a scale from negligible (0-10) to severe (40+). This company received an ESG Risk Rating of 33, placing it in the "high risk" category (retrieved April 2025).
Information
CSR claims
This company has Corporate Social Responsibility claims on its website.
> About the Icons

Company Details

Type:
Public company
Founded:
1996
Revenue:
1 billion USD (2022)
Employees:
535 (2022)
Subsidiaries:
CB Fleet Company Inc
Personal health products
Acquired by Prestige Consumer Healthcare in 2017.
Care Pharmaceuticals Pty Ltd
Healthcare products
Established in Australia in 1986 and acquired by Prestige Brands in 2013.

Contact Details

Address:
Tarrytown, New York, USA
Website:
www.prestigebrands.com

Products / Brands

Care Pharmaceuticals
Murine Eye & Ear Care